Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-16-004237
Filing Date
2016-04-14
Accepted
2016-04-14 16:02:44
Documents
91
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K biostarpharma10k123115.htm 10-K 2047318
2 EX-21 ex21.htm EX-21 5518
3 EX-23.1 ex23-1.htm EX-23.1 6663
4 EX-23.2 ex23-2.htm EX-23.2 5322
5 EX-23.3 ex23-3.htm EX-23.3 5609
6 EX-31.1 ex31-1.htm EX-31.1 17590
7 EX-31.2 ex31-2.htm EX-31.2 17730
8 EX-32.1 ex32-1.htm EX-32.1 8057
9 EX-32.2 ex32-2.htm EX-32.2 6754
16 GRAPHIC diagram1.jpg GRAPHIC 38859
17 GRAPHIC logo.jpg GRAPHIC 5627
  Complete submission text file 0001185185-16-004237.txt   8378311

Data Files

Seq Description Document Type Size
10 EX-101.INS bspm-20151231.xml EX-101.INS 1977189
11 EX-101.SCH bspm-20151231.xsd EX-101.SCH 69207
12 EX-101.CAL bspm-20151231_cal.xml EX-101.CAL 57596
13 EX-101.DEF bspm-20151231_def.xml EX-101.DEF 338320
14 EX-101.LAB bspm-20151231_lab.xml EX-101.LAB 404274
15 EX-101.PRE bspm-20151231_pre.xml EX-101.PRE 340471
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34708 | Film No.: 161571762
SIC: 2834 Pharmaceutical Preparations